NLRP3 and hepatocellular carcinoma: Recent studies have demonstrated that excessive activation of the NLRP3 inflammasome enhances the invasion and metastasis of multiple tumours, including melanoma, hepatocellular carcinoma and pancreatic cancer (59–63).